Patients on Eli Lilly’s next-generation obesity shot lost nearly 30% of their body weight on average in a trial that tracked them for a little more than a year—a result that’s far better than the most ...

Eli Lilly on Monday, Dec. 1 slashed prices of its blockbuster weight loss drug Zepbound for consumers who buy the prescription medication directly from the drugmaker. Lilly's price cuts ranged from ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. By Gina Kolata Gina Kolata has ...

Dec 1 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it has lowered the price of single-dose vials of its popular obesity drug Zepbound to make the treatment more affordable for U.S.

Eli Lilly LLY1.84%increase; green up pointing triangle said its next generation weight-loss drug retatrutide helped people lose up to 28.7% of their body weight after more than a year of treatment, ...

Eli Lilly’s experimental weight-loss drug retatrutide led to an average weight reduction of up to 28.7%—more than 71 pounds—in adults with obesity or overweight and knee osteoarthritis. Participants ...

The Influencer Lilly Gaddis has claimed that her YouTube channel has been demonetized for being “too pro-White.” Gaddis, who has a following of over 240,000 on X and over 60,000 on Instagram, ...

The stock recently reached beyond $1,000. Investors generally don't turn to pharmaceutical stocks with expectations of high growth in a short period of time. Instead, they scoop up these players for ...

Eli Lilly said its next generation weight-loss drug retatrutide resulted in significant weight loss and reduced knee pain in a late-stage trial. The company said the drug delivered weight loss of up ...

Eli Lilly's experimental weight-loss drug retatrutide resulted in significant weight loss and reduced knee pain in a phase three trial involving patients with obesity and knee osteoarthritis. The ...

Kenneth Custer is the president of Lilly Cardiometabolic Health. "Eli Lilly Reports Positive Results From Study of Weight Loss Drug for Patients with Osteoarthritis ...